New animal model for Gastrointestinal Stromal Tumor
Gastrointestinal stromal tumor (GIST) is one of the most common mesenchymal tumors of the gastrointestinal tract. GISTs occur in 10-20 per one million people. Thus, GIST has been named as an orphan drug disease. Scientists at the University of Göttingen developed a new animal drug screening model for GIST, which is caused by dysfunction of the Hedgehog pathway.
Typically, GIST formation is driven by mutations in the KIT/CD117 gene. However, not all tumors are driven by those mutations. Hence, there is a need for animal models reflecting this situation.
Gross appearance of tumors of KO mice. Source: Penelope Pelczar.
Scientists at the University of Göttingen developed a new animal drug screening model for GIST, which is caused by dysfunction of the Hedgehog pathway. This is the first immunological GIST mouse model with an aberrant Hedgehog signaling independent of Kit, demonstrating the importance of this particular pathway in GIST formation.
Tumors of this novel mouse model have a GIST-like histology. Source: Walter J. Schulz-Schaeffer.
Tumors of GIST-mice are responsive to Imatinib, which is used in the treatment of human GIST. Source: Penelope Pelczar.
No IPR. We are selling/licensing this mouse model.
Pelczar et al.: Inactivation of Patched1 in Mice Leads to Development of Gastrointestinal Stromal-Like Tumors that Express Pdgfr alpha but not Kit. Gastroenterology, 2013, 144:134 –144.
Dr. Stefan Uhle